Immune cell regulation by vitamin D-3 during allogeneic hematopoietic stem cell transplantation (HSCT) (2020) Flamann C, Zeun J, Kremer A, Peter K, Kreutz M, Büttner-Herold M, Kellner C, et al. Conference contribution Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - a single center retrospective efficacy analysis (2020) Sattler C, Hoffmann P, Weber D, Holler B, Fehn U, Plentz A, Beckhove P, et al. Conference contribution Stroma cells promote a S100A8/A9(high) subset of chemoresistant AML blasts with distinct metabolic features in a Jak/STAT-dependent manner (2020) Böttcher M, Panagiotidis K, Mentz K, Popp S, Geyh S, Jaeger P, Schroeder T, et al. Conference contribution Can we starve leukemia? Metabolic needs of MLL (2020) Garcia-Cuellar MP, Lawlor J, Böttcher M, Mougiakakos D, Metzler M, Slany R Conference contribution A murine, myc-driven lymphoma model expressing human CD22 enables testing of targeted therapies and their effects on tumor immune microenvironment (2020) Gsottberger F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F Conference contribution Blocking counter regulation of unfolded protein response by targeted protein synthesis inhibition produces highly synergistic cell death in several cancer entities (2020) Müller F, Gsottberger F, Meier C, Petkovic S, Krumbholz M, Metzler M, Mackensen A Conference contribution Stromal cells enhance PD-L1 expression on CLL cells via the oncogenic Notch-cMyc-EZH2 signaling axis (2020) Böttcher M, Mentz K, Popp S, Saul D, Bruns H, Mackensen A, Mougiakakos D, Völkl S Conference contribution N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells (2020) Strauch V, Saul D, Mackensen A, Jitschin R, Mougiakakos D Conference contribution Immunometabolic alterations in lymphoma patients with early relapse upon autologous stem cell transplantation (2020) Richter S, Jacobs B, Mackensen A, Mougiakakos D, Völkl S Conference contribution Low-dose interleukin-2 for the treatment of glucocorticoid-refractory acute graft-versus-host disease: a single center experience (2020) Brandt A, Vasova I, Winkler J, Mackensen A, Rösler W, Spoerl S, Völkl S Conference contribution